Ultragenyx, the bio-pharmaceutical company conducting the clinical trial with Sialic Acid -extended release and immediate release has announced positive data from their phase 2 study, The company presented some of this information prior to this, however the data now seems to have more details.
I hope the graphs and charts I have posted here are legible. Please feel free to contact me if you have any questions.
